DS Asset Management is an asset management investment firm based in Seoul, South Korea, founded in 2008. The firm specializes in investing in listed companies and venture firms, with a commitment to managing long-term yields. It plays a crucial role in the social safety net, particularly in relation to public and private pensions, by striving to meet the evolving needs of its clients. Through its focused investment approach, DS Asset Management aims to contribute to sustainable financial growth while ensuring the security of assets for its stakeholders.
AIMMO is a company that specializes in developing a cloud-based data annotation platform aimed at connecting users with data through artificial intelligence solutions. Founded in 2016 by SeungTaek Oh and headquartered in Seongnam-si, Gyeonggi-do, Republic of Korea, AIMMO offers a self-serve annotation platform featuring custom workflow designs, annotation tools, and an intuitive user interface. The company also provides workforce services, offering skilled annotators to support businesses in managing their data needs effectively. AIMMO’s technology enables real-time communication and includes analytics for labelers, facilitating end-to-end solutions for various data annotation requirements.
Gopizza
Series C in 2022
Gopizza Inc. is a pizza restaurant chain based in Mapo-gu, Seoul, South Korea, founded in 2016. The company specializes in providing affordable personal-sized pizzas made from quality ingredients, ensuring that customers can enjoy delicious meals at reasonable prices. Gopizza operates through mobile delivery vans and outlets located in public spaces and market complexes, making its offerings accessible to a wide audience. The company has developed a unique par-bake dough and oven system that allows small kitchens to produce large quantities of pizza efficiently with minimal staff. Customers can customize their pizzas with various toppings, further enhancing their dining experience. In addition to its restaurant operations, Gopizza also offers franchising services, allowing for expansion and growth within the food industry.
WHYNOT Media
Series C in 2022
WHYNOT Media Co., Ltd. is a South Korean company established in 2016 that specializes in developing and operating a video content streaming platform. The company offers a diverse range of entertainment, including web series, short films, and web dramas. Some of its notable web series are "Secret Crushes," "Always a Boyfriend," "Never a Boyfriend," and "Office Watch." WHYNOT Media focuses on creating engaging content that resonates with various cultural backgrounds, providing viewers with easily accessible entertainment. In addition to original productions, the company also engages in content IP production, branded content, and transmedia storytelling, further enhancing its offerings in the realm of web entertainment.
Monolith
Seed Round in 2022
Monolith Inc., founded in 2014 and based in Jeju, South Korea, specializes in the development of mobile games. Additionally, the company focuses on creating smart parks that integrate technology with play spaces for children, offering innovative recreational solutions. Through its dual approach, Monolith aims to enhance children's play experiences while leveraging technological advancements in its gaming and park designs.
Y-Biologics
Venture Round in 2022
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a unique bispecific antibody platform technology known as AliCE, which retains the structure of the parental antibody to ensure high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL library, which comprises a diverse range of antibodies. The company also offers contract research services, further contributing to its position in the antibody drug market. Through its innovative technologies and research efforts, Y-Biologics aims to advance its portfolio of antibody drugs and strengthen its role in the global immuno-chemotherapeutic landscape.
Law&Company
Series C in 2022
Law&Company is representative legal tech company in Republic of Korea. The company provides a service called 'LawTalk(www.lawtalk.co.kr)', which is the largest online legal market place in Korea(5 times bigger then the 2nd player). Since 2016, the company invested on research about Artificial Intelligence especially on Text Mining and Machine Learning technology to analyze lawyers and client's activities in the service which helps to lawyers and clients find the right person based on their experience. Also, the company will launch document automation based service to generate legal documents starting from complaint and contract soon. The company has received more than 3 million dollars from 5 venture capital companies and many angel investors due to previous performance and upside potential in the Korean legal market.
Aimmo
Series A in 2022
AIMMO is a company that specializes in developing a cloud-based data annotation platform aimed at connecting users with data through artificial intelligence solutions. Founded in 2016 by SeungTaek Oh and headquartered in Seongnam-si, Gyeonggi-do, Republic of Korea, AIMMO offers a self-serve annotation platform featuring custom workflow designs, annotation tools, and an intuitive user interface. The company also provides workforce services, offering skilled annotators to support businesses in managing their data needs effectively. AIMMO’s technology enables real-time communication and includes analytics for labelers, facilitating end-to-end solutions for various data annotation requirements.
Brandi
Series C in 2021
Brandi is a vertical commerce company based in Seoul, South Korea, specializing in both business-to-consumer and business-to-business platforms for fashion and beauty shopping. Founded in 2014, Brandi offers a diverse range of products, including clothing, cosmetics, and home interior items. The company's retail platform connects manufacturers, wholesalers, and consumers, creating a comprehensive fashion ecosystem that enables customers to access trending products at affordable prices. Through its innovative approach, Brandi aims to empower young shoppers and enhance their shopping experience in the fashion industry.
D&D Pharmatech
Series C in 2021
D&D Pharmatech Co., Ltd. is a clinical-stage global biotech company based in Seongnam, South Korea, founded in 2014. The company focuses on developing therapeutic medicines for various indications, including neurodegenerative diseases, metabolic disorders, fibrotic diseases, and molecular imaging and radiotherapy. D&D Pharmatech operates as a holding company, funding the development of disease-specific subsidiaries led by esteemed medical research faculty. Its product pipeline aims to translate advanced research into effective therapeutic solutions. The company also engages in specialized projects such as developing positron emission tomography (PET) imaging biomarkers through its subsidiary, Precision Molecular Inc., and single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. D&D Pharmatech employs innovative drug delivery technologies, including PEGylation, to enhance treatment efficacy and patient outcomes.
Orum Therapeutics
Series B in 2021
Orum Therapeutics is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of therapeutic antibodies through its innovative cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's unique approach allows for the intracellular delivery of active antibody therapeutics or payloads, enabling the inhibition of drug targets that have been previously considered undruggable by conventional small molecules or antibody therapies. Orum's technology is adaptable to various cell types and intracellular proteins without requiring chemical modifications, aiming to develop effective treatments with improved specificity and reduced toxicity.
GI Innovation
Series C in 2021
GI Innovation is a South Korean bio-venture company dedicated to the research and development of innovative biologics aimed at treating immuno-oncology and inflammation/immunology diseases. The company employs its proprietary GI-SMART platform technology, which optimizes the development of multi-targeting fusion protein therapeutics, ensuring high quality and productivity. Through its structured translational research approach, GI Innovation focuses on creating new protein-based drugs, particularly in the fields of immuno-oncology and allergy-related conditions, with the goal of improving patient outcomes worldwide.
DEEPX
Series B in 2021
DEEPX is a South Korean company specializing in artificial intelligence solutions, focusing on both software and hardware systems. It develops advanced neural networks that enhance AI silicon for deep learning operations. By maximizing memory bandwidth, DEEPX's technology allows edge devices to operate efficiently, supporting the latest AI applications while promoting sustainable power usage. This approach enables businesses to implement energy-efficient on-device AI technology, streamlining their operations and improving performance.
Gopizza
Series B in 2021
Gopizza Inc. is a pizza restaurant chain based in Mapo-gu, Seoul, South Korea, founded in 2016. The company specializes in providing affordable personal-sized pizzas made from quality ingredients, ensuring that customers can enjoy delicious meals at reasonable prices. Gopizza operates through mobile delivery vans and outlets located in public spaces and market complexes, making its offerings accessible to a wide audience. The company has developed a unique par-bake dough and oven system that allows small kitchens to produce large quantities of pizza efficiently with minimal staff. Customers can customize their pizzas with various toppings, further enhancing their dining experience. In addition to its restaurant operations, Gopizza also offers franchising services, allowing for expansion and growth within the food industry.
HonestFund
Series B in 2019
HonestFund Co., LTD., founded in 2015 and headquartered in Seoul, South Korea, operates an online financial platform that focuses on alternative investments. The company provides individuals and institutional investors with access to a diverse range of investment opportunities, including residential and commercial real estate, infrastructure financing, unsecured personal loans, and various bond investment products. HonestFund is distinguished by its transparent and streamlined process, which facilitates investment for both investors and private issuers. The company has successfully raised capital from prominent financial institutions, enhancing its credibility in the market.
Law&Company
Series B in 2019
Law&Company is representative legal tech company in Republic of Korea. The company provides a service called 'LawTalk(www.lawtalk.co.kr)', which is the largest online legal market place in Korea(5 times bigger then the 2nd player). Since 2016, the company invested on research about Artificial Intelligence especially on Text Mining and Machine Learning technology to analyze lawyers and client's activities in the service which helps to lawyers and clients find the right person based on their experience. Also, the company will launch document automation based service to generate legal documents starting from complaint and contract soon. The company has received more than 3 million dollars from 5 venture capital companies and many angel investors due to previous performance and upside potential in the Korean legal market.
ZigBang
Venture Round in 2019
ZigBang Co., Ltd. is a South Korean company founded in 2010, specializing in a property listing platform that connects real estate agents with renters. The company offers a user-friendly marketplace for apartment hunting through its mobile and web applications, allowing users to search for rental properties based on criteria such as the number of rooms, occupants, and price. ZigBang has reported approximately 6 million users, although this figure includes both active and inactive accounts. The platform aims to simplify the rental process and help users make informed choices while potentially saving money on housing.
Wadiz
Series C in 2019
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.
BOMAPP
Series A in 2019
Bomapp Inc., founded in 2015 and based in Seoul, South Korea, specializes in developing a mobile application designed to streamline the insurance purchasing process for users. The Bomapp app serves as an integrated insurance manager, allowing users to review and purchase various insurance products while providing personalized coverage reports to enhance consumer understanding. Key features of the app include policy monitoring, product comparisons, and easy claims submission, all aimed at making insurance more accessible and engaging. As of mid-2020, the app had achieved 2.2 million downloads and 1.7 million registered users. In addition to its business-to-consumer offerings, Bomapp is expanding into business-to-business and business-to-business-to-consumer markets, addressing the insurance needs of small and medium-sized enterprises and platform service providers. The company continues to focus on enhancing its digital insurance experience, aiming to simplify the entire process from comparison to application through personalized coverage options.
Brandi
Venture Round in 2019
Brandi is a vertical commerce company based in Seoul, South Korea, specializing in both business-to-consumer and business-to-business platforms for fashion and beauty shopping. Founded in 2014, Brandi offers a diverse range of products, including clothing, cosmetics, and home interior items. The company's retail platform connects manufacturers, wholesalers, and consumers, creating a comprehensive fashion ecosystem that enables customers to access trending products at affordable prices. Through its innovative approach, Brandi aims to empower young shoppers and enhance their shopping experience in the fashion industry.
Brandi
Series B in 2019
Brandi is a vertical commerce company based in Seoul, South Korea, specializing in both business-to-consumer and business-to-business platforms for fashion and beauty shopping. Founded in 2014, Brandi offers a diverse range of products, including clothing, cosmetics, and home interior items. The company's retail platform connects manufacturers, wholesalers, and consumers, creating a comprehensive fashion ecosystem that enables customers to access trending products at affordable prices. Through its innovative approach, Brandi aims to empower young shoppers and enhance their shopping experience in the fashion industry.
SCM Lifescience
Series C in 2018
SCM Lifescience, founded in 2014, focuses on the research and development of innovative treatment options for challenging diseases, aiming to improve patient outcomes and contribute to public health. The company specializes in proprietary stem cell isolation and production technologies, which form the basis of its products, including medicines and hair care solutions. Based in South Korea, SCM Lifescience is committed to advancing medical science through its development of stem cell products and therapies, providing hope for patients with difficult-to-treat conditions.
Air Premia
Seed Round in 2018
Air Premia Inc. is an airline company based in Seoul, South Korea, founded in 2017. It specializes in commercial air carrier services, operating wide-body aircraft on medium and long-haul routes to destinations across the Americas, Asia, and Europe. The company aims to enhance consumer comfort by providing comfortable seating options and offering a range of pricing tiers, from economical to first-class, at competitive rates. Additionally, Air Premia provides in-flight services and ticketing, striving to ensure a pleasant travel experience for its customers.
G+FLAS Life Sciences
Series B in 2018
G+FLAS Life Sciences Co., Ltd., founded in 2014 and based in Seoul, South Korea, specializes in agricultural biotechnology with a focus on genome editing applications. Utilizing advanced CRISPR-Cas technology, the company develops innovative products such as glycoengineered humanized plants, which involve the selective removal of glycosylation-related genes. A flagship product is the vitamin D3-enriched tomato, aimed at enhancing nutritional value and addressing market demand for functional foods. This product not only serves the health-conscious consumer but also provides a plant-based alternative to traditional vitamin D supplements, catering to various dietary needs. G+FLAS has established a strategic partnership with Bayer, facilitating the commercialization of its technology and enhancing its position in the agricultural market. The company is also engaged in drug research and development, utilizing its gene therapy expertise to support healthcare organizations and pharmaceutical companies. G+FLAS Life Sciences is well-positioned for growth, targeting significant market share and aiming to accelerate expansion in the U.S. and beyond.
ABL Bio
Series C in 2018
ABL Bio Inc. is a South Korean biotech research company dedicated to developing therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company's pipeline includes ABL001, a bispecific antibody for cancer immunotherapy, and several antibody-drug conjugates (ADCs) such as ABL201-205. Additionally, ABL Bio is working on T cell engagers and dual immune cell targeting bispecific antibodies to enhance immuno-oncology treatments. Another notable product in development is ABL301, designed as a blood-brain barrier-penetrating bispecific antibody. The company emphasizes innovation and collaboration in its mission to improve lives through novel therapies.
Chain Partners
Series A in 2018
Chain Partners, Inc. specializes in blockchain technology, offering a range of services that include cryptocurrency conversion and payment solutions. Founded in 2017 and headquartered in Seoul, South Korea, the company has developed Coinduck, an Ethereum-based offline payment service that facilitates payments and wire transfers using Ethereum coins. Additionally, Chain Partners operates Changer, a platform designed for active traders to convert cryptocurrencies efficiently. Changer allows users to access competitive prices across major over-the-counter (OTC) markets and execute trades without navigating complex workflows. This service is particularly beneficial for individual traders, as it simplifies onboarding and eliminates minimum transaction requirements, enabling them to maximize their trading potential.
OTD
Series A in 2017
OTD operates a diverse portfolio of gourmet restaurants and food courts throughout South Korea, primarily located in office buildings and shopping malls. The company focuses on delivering a variety of dining options under multiple brands, catering to the tastes of the general public while maintaining affordable pricing. By creating vibrant food courts that showcase different culinary offerings, OTD aims to enhance the dining experience for customers seeking convenience and quality.
H2O Hospitality
Series B in 2017
H2O Hospitality, Ltd. is a leading hospitality management company operating in South Korea and Japan, specializing in hotel and vacation rental management services. Established in 2015 and based in Seoul, the company leverages technology to automate operational processes, significantly reducing fixed costs and enhancing efficiency. H2O Hospitality offers a comprehensive range of services, including profit management, housekeeping and facility management, customer call response, online marketing, and reservation management. Its proprietary property management system (PMS) enables seamless coordination between guests, accommodations, and housekeeping, facilitating smoother operations without the need for on-site staff. This innovative approach allows H2O to optimize customer attraction and streamline reservation management, thereby supporting property owners in effectively managing their rental facilities.
Market Kurly
Series A in 2016
Market Kurly is an online grocery service based in Seoul, South Korea, that specializes in the delivery of fresh and premium food products. Founded in 2014, the platform allows users to order a wide range of items, including vegetables, fruits, meats, dairy, baked goods, and processed foods, all sourced directly from producers. Market Kurly focuses on providing high-quality ingredients and offers next-day delivery, ensuring that customers receive their orders promptly. The service also includes non-perishable items, enabling shoppers to conveniently access a variety of groceries. Through its innovative logistics and delivery system, Market Kurly aims to enhance the grocery shopping experience by transforming the way food is produced and distributed.
Eutilex
Series A in 2016
Eutilex Co., Ltd. is a biotechnology company based in South Korea that specializes in the development of immunotherapy technologies aimed at treating tumors. The company focuses on anti-tumor T cell therapy and antibody therapeutics, creating innovative treatments to combat cancer. Eutilex's product pipeline includes advanced therapies such as T Cell Therapy (4-1BB CTL), CAR-T, and various antibody-based treatments. The company markets its offerings throughout South Korea, contributing to the growing field of cancer immunotherapy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.